Abstract | AIM: To investigate cardiac signalling pathways connecting substrate utilization with left ventricular remodelling in a murine pressure overload model. METHODS: RESULTS: CONCLUSION: SGLT2 inhibition reduced left ventricular fibrosis in a murine model of cardiac hypertrophy. Mechanistically, this was associated with reduced cardiac insulin and increased AMPK signalling as a potential mechanism for less cardiac mTOR activation with alleviation of downstream ER stress, UPR and apoptosis.
|
Authors | Julia Moellmann, Pascal A Mann, Ben A Kappel, Florian Kahles, Barbara M Klinkhammer, Peter Boor, Rafael Kramann, Bart Ghesquiere, Corinna Lebherz, Nikolaus Marx, Michael Lehrke |
Journal | Diabetes, obesity & metabolism
(Diabetes Obes Metab)
Vol. 24
Issue 11
Pg. 2263-2272
(11 2022)
ISSN: 1463-1326 [Electronic] England |
PMID | 35801343
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. |
Chemical References |
- Bridged Bicyclo Compounds, Heterocyclic
- Fatty Acids
- Insulins
- Keto Acids
- Ketones
- Sodium-Glucose Transporter 2
- Sodium-Glucose Transporter 2 Inhibitors
- ertugliflozin
- Adenosine Triphosphate
- Sodium
- Hydroxybutyrate Dehydrogenase
- Acetyl-CoA C-Acetyltransferase
- TOR Serine-Threonine Kinases
- AMP-Activated Protein Kinases
- Coenzyme A-Transferases
- Acetyl-CoA Carboxylase
- Glucose
- Sirolimus
|
Topics |
- AMP-Activated Protein Kinases
(metabolism)
- Acetyl-CoA C-Acetyltransferase
(metabolism)
- Acetyl-CoA Carboxylase
(metabolism)
- Adenosine Triphosphate
(metabolism)
- Animals
- Apoptosis
- Bridged Bicyclo Compounds, Heterocyclic
- Cardiomegaly
(metabolism, pathology)
- Coenzyme A-Transferases
(metabolism)
- Endoplasmic Reticulum Stress
- Fatty Acids
(metabolism)
- Fibrosis
- Glucose
(metabolism)
- Hydroxybutyrate Dehydrogenase
(metabolism)
- Insulins
- Keto Acids
(metabolism)
- Ketones
(metabolism)
- Mice
- Mice, Inbred C57BL
- Myocytes, Cardiac
(metabolism)
- Sirolimus
(metabolism)
- Sodium
(metabolism)
- Sodium-Glucose Transporter 2
(metabolism)
- Sodium-Glucose Transporter 2 Inhibitors
(pharmacology, therapeutic use)
- TOR Serine-Threonine Kinases
(metabolism)
|